Forss responded that MatTek drove consumables growth, while CELLINK faced challenges. She highlighted efforts to enhance recurring revenues through standardized procedures and service contracts.

Strengthened profitability in a challenging market environment and further reduced debt"We finished the year with strengthened profitability and operational ...

United Kingdom 3D Bioprinted Human Tissue MarketThe United Kingdom’s 3D bioprinted human tissue market is poised for significant expansion, with the market size projected to increase from USD 52.0 ...

South Korea’s 3D Bioprinted Human Tissue MarketThe South Korea 3D bioprinted human tissue market is poised for impressive growth, with projections indicating a market size of USD 108.1 million by 2035 ...

Q4 2024 Management View CEO Maria Forss highlighted that Q4 2024 revenue remained steady year-over-year at SEK571 million, with a 12 percentage point improvement in adjusted EBITDA margin, reaching 25 ...

BICO Group AB reported its fourth-quarter 2024 earnings, revealing a slight year-over-year sales growth and a significant improvement in adjusted EBITDA margins. The company's stock price surged 14.56 ...